C. Sturgeon

Pregnant women with impaired tolerance to an oral glucose load in the afternoon: evidence suggesting that they behave metabolically as patients with gestational diabetes.

N. Aparicio, M. Guz, M. Cortelezzi, 1998, American journal of obstetrics and gynecology.

Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.

M. Duffy, C. Haglund, R. Klapdor, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper

Callum G Fraser, Rolf Lamerz, C. Haglund, 2011, International journal of cancer.

The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.

R. A. Badley, J. E. Roulston, R. Leonard, 1993, British Journal of Cancer.

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

C. Haglund, R. Lamerz, C. Sturgeon, 2013, International journal of cancer.

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.

G. Beattie, J. E. Roulston, M. Stewart, 1993, British Journal of Cancer.

Serum tumour markers: how to order and interpret them

M. Duffy, C. Sturgeon, M. Duffy, 2009, BMJ : British Medical Journal.

A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery.

K. Fearon, C. Sturgeon, T. Cooke, 1995, American journal of surgery.

Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper

C. Haglund, R. Lamerz, A. Nicolini, 2011, International journal of cancer.